🇺🇸 FDA
Patent

US 7803913

Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries

granted A61KA61K2039/505A61P

Quick answer

US patent 7803913 (Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61P, A61P31/04, A61P31/12